EAM Investors, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q2 2020$1,716,000
-19.6%
18,014
-24.2%
0.38%
-42.8%
Q1 2020$2,135,000
+55.0%
23,759
-24.9%
0.66%
+77.3%
Q4 2018$1,377,000
-55.0%
31,625
-40.9%
0.37%
-17.8%
Q3 2018$3,063,000
+45.4%
53,517
-5.2%
0.46%
+62.5%
Q3 2017$2,106,000
+40.4%
56,427
+49.0%
0.28%
+4.1%
Q4 2013$1,500,00037,8710.27%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders